1Capocaccia R,Sant M,Berrino F,et al.Hepatocellular carcinoma:trends of incidence and survival in Europe and the United States at the end of the 20th century[J].Am J Gastroenterol,2007,102 (8):1661-1671.
2Gooden MJ,De Bock GH,Leffers N,et al.The prognostic influence of tumour-infiltrating lymphocytes in cancer:a systematic review with meta-analysis[J].Br J Cancer,2011,105 (1):93-103.
3Anraku M,Cunningham KS,Yun Z,et al.Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma[J].J Thorac Cardiovasc Surg,2008,135(4):823-829.
4Nakamura H,Saji H,Aute I,et al.Peripheral Ieukocytes with HLADR+/CD8-phenotype are associated with prognosis in patients with lung cancer[J].Anticancer Res,2003,23(5b):4149-4152.
5Nikolova M,Lelievre J D,Carriere M,et al.Regulatory T cells differentially modulate the maturation and apoptosis of human CD8 + T-cell subsets[J].Blood,2009,113(19):4556-4565.
6Kano Y,Soda K,Nakamura T,et al.Increased blood spermine levels decrease the cytotoxic activity of lymphokine-activated killer cells:a novel mechanism of cancer evasion[J].Cancer Immunol Immunother,2007,56(6):771-781.
7Konjevic G,Jovic V,Vuletic A,et al.CD69 on CD56 + NK cells and response to chemoimmunotherapy in metastatic melanoma[J].Eur J Clin Invest,2007,37(11):887-896.
8Mittal S,Marshall NA,Duncan L,et al.Local and systemic induction of CD4^+ CD25^+ regulatory T-cell population by non-Hodgkin lymphoma[J].Blood,2008,111 (1 1):5359-5370.
9Feng X,Li B,Ye H,et al.Increased Frequency of CD4(+)CD25 (high) FoxP3 (+) Regulatory T Cells in Patients with Hepatocellular Carcinoma[J].Arch Immunol Ther Exp (Warsz),2011,59(4):309-314.
9Steven A Rosenberg,Mark E Dudley.Adoptive cell therapy for the treatment of patients with metastatic melanoma[J]. Current Opinion in Immunology . 2009 (2)
